560 Appendices 43. Lee SR, Jung CK, Kim TE, Bae JS, Jung SL, Choi YJ, et al. Molecular genotyping of follicular variant of papillary thyroid carcinoma correlates with diagnostic category of fine-needle aspiration cytology: values of RAS mutation testing. Thyroid. 2013;23:1416-1422. https://doi.org/10.1089/thy.2012.0640. 44. Cibas ES, Ali SZ, Conference NCITFSotS. The Bethesda System For Reporting Thyroid Cytopathology. American journal of clinical pathology. 2009;132:658-665. https://doi.org/10.1309/AJCPPHLWMI3JV4LA. 45. Mitchell AL, Gandhi A, Scott-Coombes D, Perros P. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines. The Journal of laryngology and otology. 2016;130:S150-S160. https://doi.org/10.1017/ S0022215116000578. 46. Nardi F, Basolo F, Crescenzi A, Fadda G, Frasoldati A, Orlandi F, et al. Italian consensus for the classification and reporting of thyroid cytology. Journal of endocrinological investigation. 2014;37:593-599. https://doi.org/10.1007/ s40618-014-0062-0. 47. Brito JP, Al Nofal A, Montori VM, Hay ID, Morris JC. The Impact of Subclinical Disease and Mechanism of Detection on the Rise in Thyroid Cancer Incidence: A Population-Based Study in Olmsted County, Minnesota During 1935 Through 2012. Thyroid. 2015;25:999-1007. https://doi.org/10.1089/thy.2014.0594. 48. Fazeli R, Schneider EB, Ali SZ, Zeiger MA, Olson MT. Diagnostic Frequency Ratios Are Insufficient to Measure Laboratory Precision with The Bethesda System for Reporting Thyroid Cytopathology. Acta cytologica. 2015;59:225232. https://doi.org/10.1159/000379738. 49. Bongiovanni M, Spitale A, Faquin WC, Mazzucchelli L, Baloch ZW. The Bethesda System for Reporting Thyroid Cytopathology: a meta-analysis. Acta cytologica. 2012;56:333-339. https://doi.org/10.1159/000339959. 50. Sullivan PS, Hirschowitz SL, Fung PC, Apple SK. The impact of atypia/follicular lesion of undetermined significance and repeat fine-needle aspiration: 5 years before and after implementation of the Bethesda System. Cancer cytopathology. 2014;122:866-872. https://doi.org/10.1002/cncy.21468. 51. Caplan RH, Wester SM, Lambert PJ, Rooney BL. Efficient evaluation of thyroid nodules by primary care providers and thyroid specialists. The American journal of managed care. 2000;6:1134-1140. 52. Khalid AN, Quraishi SA, Hollenbeak CS, Stack BC, Jr. Fine-needle aspiration biopsy versus ultrasound-guided fineneedle aspiration biopsy: cost-effectiveness as a frontline diagnostic modality for solitary thyroid nodules. Head & neck. 2008;30:1035-1039. https://doi.org/10.1002/hed.20829. 53. Vriens D, Adang EM, Netea-Maier RT, Smit JW, de Wilt JH, Oyen WJ, et al. Cost-effectiveness of FDG-PET/CT for cytologically indeterminate thyroid nodules: a decision analytic approach. The Journal of clinical endocrinology and metabolism. 2014;99:3263-3274. https://doi.org/10.1210/jc.2013-3483. 54. McHenry CR, Slusarczyk SJ. Hypothyroidisim following hemithyroidectomy: incidence, risk factors, and management. Surgery. 2000;128:994-998. https://doi.org/10.1067/msy.2000.110242. 55. Rosato L, Avenia N, Bernante P, De Palma M, Gulino G, Nasi PG, et al. Complications of thyroid surgery: analysis of a multicentric study on 14,934 patients operated on in Italy over 5 years. World journal of surgery. 2004;28:271-276. https://doi.org/10.1007/s00268-003-6903-1. 56. Jeannon JP, Orabi AA, Bruch GA, Abdalsalam HA, Simo R. Diagnosis of recurrent laryngeal nerve palsy after thyroidectomy: a systematic review. Int J Clin Pract. 2009;63:624-629. https://doi.org/10.1111/j.1742-1241.2008.01875.x. 57. Samir AE, Dhyani M, Anvari A, Prescott J, Halpern EF, Faquin WC, et al. Shear-Wave Elastography for the Preoperative Risk Stratification of Follicular-patterned Lesions of the Thyroid: Diagnostic Accuracy and Optimal Measurement Plane. Radiology. 2015:141627. https://doi.org/10.1148/radiol.2015141627. 58. Piccardo A, Puntoni M, Treglia G, Foppiani L, Bertagna F, Paparo F, et al. Thyroid nodules with indeterminate cytology: prospective comparison between 18F-FDG-PET/CT, multiparametric neck ultrasonography, 99mTc-MIBI scintigraphy and histology. European journal of endocrinology. 2016. https://doi.org/10.1530/eje-15-1199. 59. Munoz Perez N, Villar del Moral JM, Muros Fuentes MA, Lopez de la Torre M, Arcelus Martinez JI, Becerra Massare P, et al. Could 18F-FDG-PET/CT avoid unnecessary thyroidectomies in patients with cytological diagnosis of follicular neoplasm? Langenbeck’s archives of surgery / Deutsche Gesellschaft fur Chirurgie. 2013;398:709-716. https://doi. org/10.1007/s00423-013-1070-9. 60. Nikiforov YE, Carty SE, Chiosea SI, Coyne C, Duvvuri U, Ferris RL, et al. Impact of the Multi-Gene ThyroSeq NextGeneration Sequencing Assay on Cancer Diagnosis in Thyroid Nodules with Atypia of Undetermined Significance/ Follicular Lesion of Undetermined Significance Cytology. Thyroid. 2015;25:1217-1223. https://doi.org/10.1089/ thy.2015.0305. 61. Labourier E, Shifrin A, Busseniers AE, Lupo MA, Manganelli ML, Andruss B, et al. Molecular Testing for miRNA, mRNA, and DNA on Fine-Needle Aspiration Improves the Preoperative Diagnosis of Thyroid Nodules With Indeterminate Cytology. The Journal of clinical endocrinology and metabolism. 2015;100:2743-2750. https://doi.org/10.1210/ jc.2015-1158. 62. Kimura ET, Nikiforova MN, Zhu Z, Knauf JA, Nikiforov YE, Fagin JA. High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Res. 2003;63:1454-1457.
RkJQdWJsaXNoZXIy MTk4NDMw